Correlation Between Seres Therapeutics and Oncolytics Biotech
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Oncolytics Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Oncolytics Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Oncolytics Biotech, you can compare the effects of market volatilities on Seres Therapeutics and Oncolytics Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Oncolytics Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Oncolytics Biotech.
Diversification Opportunities for Seres Therapeutics and Oncolytics Biotech
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Seres and Oncolytics is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Oncolytics Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncolytics Biotech and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Oncolytics Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncolytics Biotech has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Oncolytics Biotech go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Oncolytics Biotech
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 1.79 times more return on investment than Oncolytics Biotech. However, Seres Therapeutics is 1.79 times more volatile than Oncolytics Biotech. It trades about 0.05 of its potential returns per unit of risk. Oncolytics Biotech is currently generating about -0.3 per unit of risk. If you would invest 84.00 in Seres Therapeutics on November 2, 2024 and sell it today you would earn a total of 2.00 from holding Seres Therapeutics or generate 2.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Oncolytics Biotech
Performance |
| Timeline |
| Seres Therapeutics |
| Oncolytics Biotech |
Seres Therapeutics and Oncolytics Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Oncolytics Biotech
The main advantage of trading using opposite Seres Therapeutics and Oncolytics Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Oncolytics Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will offset losses from the drop in Oncolytics Biotech's long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| Oncolytics Biotech vs. Scpharmaceuticals | Oncolytics Biotech vs. Milestone Pharmaceuticals | Oncolytics Biotech vs. Seres Therapeutics | Oncolytics Biotech vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |